Capital Fund Management (CFM)’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-33,559
| Closed | -$9.17M | – | 2652 |
|
|
2025
Q2 | $8.66M | Sell |
33,559
-1,310
| -4% | -$312K | 0.02% | 839 |
|
|
2025
Q1 | $7.81M | Sell |
34,869
-8,408
| -19% | -$1.96M | 0.02% | 799 |
|
|
2024
Q4 | $9.9M | Buy |
43,277
+3,234
| +8% | +$779K | 0.03% | 755 |
|
|
2024
Q3 | $9.78M | Buy |
+40,043
| New | +$8.95M | 0.03% | 742 |
|
|
2023
Q4 | – | Sell |
-79,098
| Closed | -$12.2M | – | 2272 |
|
|
2023
Q3 | $11.7M | Buy |
79,098
+11,661
| +17% | +$2.11M | 0.04% | 550 |
|
|
2023
Q2 | $14.7M | Buy |
67,437
+40,930
| +154% | +$9.12M | 0.06% | 429 |
|
|
2023
Q1 | $5.8M | Buy |
+26,507
| New | +$5.75M | 0.03% | 685 |
|
|
2020
Q3 | – | Sell |
-12,066
| Closed | -$2.32M | – | 1365 |
|
|
2020
Q2 | $2.32M | Sell |
12,066
-26,674
| -69% | -$4.36M | 0.04% | 458 |
|
|
2020
Q1 | $5.71M | Sell |
38,740
-10,358
| -21% | -$1.65M | 0.09% | 283 |
|
|
2019
Q4 | $7.61M | Buy |
+49,098
| New | +$7.08M | 0.06% | 416 |
|
|
2019
Q1 | – | Sell |
-20,371
| Closed | -$2.32M | – | 2033 |
|
|
2018
Q4 | $2.32M | Sell |
20,371
-68,800
| -77% | -$7.37M | 0.02% | 781 |
|
|
2018
Q3 | $10.3M | Buy |
89,171
+8,900
| +11% | +$975K | 0.06% | 480 |
|
|
2018
Q2 | $8.31M | Buy |
+80,271
| New | +$8.12M | 0.04% | 541 |
|
|
2016
Q4 | – | Sell |
-7,560
| Closed | -$490K | – | 1830 |
|
|
2016
Q3 | $490K | Buy |
+7,560
| New | +$503K | ﹤0.01% | 1205 |
|
|
2016
Q2 | – | Sell |
-37,000
| Closed | -$2.14M | – | 1739 |
|
|
2016
Q1 | $2.14M | Sell |
37,000
-89,758
| -71% | -$5.08M | 0.02% | 688 |
|
|
2015
Q4 | $6.81M | Sell |
126,758
-53,532
| -30% | -$3.02M | 0.07% | 368 |
|
|
2015
Q3 | $9.19M | Buy |
180,290
+173,890
| +2,717% | +$9.36M | 0.1% | 255 |
|
|
2015
Q2 | $361K | Buy |
+6,400
| New | +$404K | ﹤0.01% | 1190 |
|
|
2014
Q4 | – | Sell |
-47,207
| Closed | -$2.33M | – | 1770 |
|
|
2014
Q3 | $2.33M | Buy |
+47,207
| New | +$2.4M | 0.03% | 632 |
|
|
2014
Q2 | – | Sell |
-39,195
| Closed | -$1.75M | – | 1891 |
|
|
2014
Q1 | $1.75M | Sell |
39,195
-11,381
| -23% | -$511K | 0.02% | 740 |
|
|
2013
Q4 | $2.38M | Buy |
50,576
+44,641
| +752% | +$2.26M | 0.03% | 637 |
|
|
2013
Q3 | $313K | Sell |
5,935
-16,483
| -74% | -$800K | ﹤0.01% | 1343 |
|
|
2013
Q2 | $1.01M | Buy |
+22,418
| New | +$1.06M | 0.02% | 805 |
|
Other funds holding RMD
Capital Fund Management (CFM)'s RMD Position: Q3 2025 in Review
Capital Fund Management (CFM) sold out of ResMed (RMD) in Q3 2025, closing a stake of 33,559 shares — an estimated $9.17M sold.
Capital Fund Management (CFM) first reported a position in RMD in Q2 2013 and held it in 23 quarters. The position peaked at $14.7M in Q2 2023. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.
- Capital Fund Management (CFM) reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
- Capital Fund Management (CFM) sold 33,559 ResMed shares in Q3 2025, an estimated $9.17M.
- Capital Fund Management (CFM) first reported a position in ResMed in Q2 2013 and held it in 23 quarters.
- Capital Fund Management (CFM)'s ResMed position peaked at $14.7M in Q2 2023.
- 949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.
Based on Capital Fund Management (CFM)'s 13F filing for Q3 2025, filed 13 Nov 2025.